许培扬博客分享 http://blog.sciencenet.cn/u/xupeiyang 跟踪国际前沿 服务国内科研

博文

中美生物医学的决斗 Nature 11月15日 信息

已有 1720 次阅读 2016-11-17 08:43 |个人分类:今日热点|系统分类:观点评述


基因编辑的国际竞争就像世界大战,你死我活。

CRISPR gene-editing tested in a person for the first time

The move by Chinese scientists could spark a biomedical duel between China and the United States.

http://www.nature.com/news/crispr-gene-editing-tested-in-a-person-for-the-first-time-1.20988

Steve Gschmeissner/Science Photo Library

Gene-editing could improve the ability of immune cells to attack cancer.

A Chinese group has become the first to inject a person with cells that contain genes edited using the revolutionary CRISPR–Cas9 technique.

On 28 October, a team led by oncologist Lu You at Sichuan University in Chengdu delivered the modified cells into a patient with aggressive lung cancer as part of a clinical trial at the West China Hospital, also in Chengdu.




https://wap.sciencenet.cn/blog-280034-1015216.html

上一篇:韩春雨 科学研究不是选总统
下一篇:韩春雨 科研保密 万无一失
收藏 IP: 120.52.94.*| 热度|

0

该博文允许注册用户评论 请点击登录 评论 (0 个评论)

数据加载中...
扫一扫,分享此博文

Archiver|手机版|科学网 ( 京ICP备07017567号-12 )

GMT+8, 2024-4-28 23:37

Powered by ScienceNet.cn

Copyright © 2007- 中国科学报社

返回顶部